These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 23551967

  • 1. A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
    Pils D, Tong D, Hager G, Obermayr E, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I, Vergote I, Van Gorp T, Mahner S, Concin N, Speiser P, Zeillinger R.
    BMC Cancer; 2013 Apr 03; 13():178. PubMed ID: 23551967
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.
    Kristjansdottir B, Levan K, Partheen K, Sundfeldt K.
    Gynecol Oncol; 2013 Oct 03; 131(1):52-8. PubMed ID: 23891789
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response.
    Hamed EO, Ahmed H, Sedeek OB, Mohammed AM, Abd-Alla AA, Abdel Ghaffar HM.
    Diagn Pathol; 2013 Jan 23; 8():11. PubMed ID: 23343214
    [Abstract] [Full Text] [Related]

  • 8. Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis.
    Bandiera E, Zanotti L, Fabricio AS, Bucca E, Squarcina E, Romani C, Tassi R, Bignotti E, Todeschini P, Tognon G, Romagnolo C, Gion M, Sartori E, Maggino T, Pecorelli S, Ravaggi A.
    Clin Chem Lab Med; 2013 Sep 23; 51(9):1815-24. PubMed ID: 24013103
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P, Åkesson A, Hedenfalk I, Malander S, Borgfeldt C.
    PLoS One; 2020 Sep 23; 15(10):e0240418. PubMed ID: 33075095
    [Abstract] [Full Text] [Related]

  • 11. Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses.
    Fawzy A, Mohamed MR, Ali MA, Abd El-Magied MH, Helal AM.
    Asian Pac J Cancer Prev; 2016 Sep 23; 17(1):323-33. PubMed ID: 26838232
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages.
    Wang Z, Tao X, Ying C.
    Dis Markers; 2019 Sep 23; 2019():6241743. PubMed ID: 31737130
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer.
    Bednarska K, Król E, Głowacka E, Romanowicz H, Szyłło K, Klink M, Sułowska Z, Nowak M.
    Medicine (Baltimore); 2018 Mar 23; 97(12):e0180. PubMed ID: 29561432
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer.
    Zheng H, Zhang L, Zhao Y, Yang D, Song F, Wen Y, Hao Q, Hu Z, Zhang W, Chen K.
    PLoS One; 2013 Mar 23; 8(11):e77853. PubMed ID: 24223734
    [Abstract] [Full Text] [Related]

  • 20. A Biomarker Panel Increases the Diagnostic Performance for Epithelial Ovarian Cancer Type I and II in Young Women.
    Leandersson P, Kalapotharakos G, Henic E, Borgfeldt H, Petzold M, Høyer-Hansen G, Borgfeldt C.
    Anticancer Res; 2016 Mar 23; 36(3):957-65. PubMed ID: 26976984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.